Tandem Diabetes Care Inc
(STU:TD5A)
€
29.15
-1.65 (-5.36%)
Market Cap: 1.92 Bil
Enterprise Value: 1.92 Bil
PE Ratio: 0
PB Ratio: 8.66
GF Score: 82/100 Tandem Diabetes Care Inc at Wells Fargo Healthcare Conference Transcript
Sep 08, 2022 / 05:55PM GMT
Release Date Price:
€45.54
(+3.18%)
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
All right. Welcome, everyone. I'm Larry Biegelsen, the medical device analyst at Wells Fargo. And it's my pleasure to host this session with Tandem Diabetes. With us, we have John Sheridan, President and CEO; and Leigh Vosseller, Executive Vice President and CFO.
In terms of format, it's going to be a fireside chat. If anybody has a question they want to ask, just raise your hand, and we'll call on you.
John and Leigh, thanks so much for being here.
John F. Sheridan
Tandem Diabetes Care, Inc. - President, CEO & Director
Thanks for having us, Larry. Good to see you again.
Questions & Answers
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
Likewise. So John, we're starting all these fireside chats with the macro environment. And on the Q2 call, you highlighted 3 headwinds that resulted in lower-than
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot